
Published On: Apr 2022
Published On: Apr 2022
According to our latest study on “Asia Pacific Retinal Imaging Devices Market Forecast to 2028 – COVID-19 Impact and Analysis – by Device Type, and End User,” the market is projected to reach US$ 801.3 million by 2028 from US$ 526.0 million in 2021; it is expected to grow at a CAGR of 6.2% from 2021 to 2028. The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as rising prevalence of eye diseases, growing initiatives for blindness and technological advancements. However, the high cost of OCT devices is expected to hamper the growth of the market during the forecast years.
The outbreak has severely affected the medical tourism industry in Asia pacific and imposed supply chain disruptions; moreover, low-income countries face additional challenges due to the shortage of healthcare infrastructure, restrictions imposed by hospitals to the suppliers, decreasing in demand for retinal imaging and surgical instruments, and others. There are various research studies on the reduction of surgeries in the Asia Pacific countries. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent disease transmission. These restrictive measures are anticipated to impact the supply chain and the availability of medical devices in these countries. It has affected disposable incomes and has also resulted in unemployment. Furthermore, business strategies such as acquisitions, mergers, and partnerships are adversely affected by the imposition of complete lockdown. However, increasing vaccination across the region and availability of government reimbursement policies for various retinal or eye surgical procedures is expected to normalize the situation in the Asia Pacific region and will gradually increase the demand for retinal imaging devices.
Based on device type, the retinal imaging devices market is segmented into fluorescein angiography, fundus camera, and optical coherence tomography. In 2020, the fundus camera segment accounted for the largest market share in the Asia Pacific retinal imaging device market by device type owing to advancement in the technology related to retina imaging technology. The optical coherence tomography is expected to be the highest growing segment during the forecast period. The growth is expected due to the factors such as growing prevalence of retina related disorders.
Carl Zeiss Meditec AG, Revenio Group Corporation (CenterVue SpA), Epipole Ltd., Eyenuk, Inc., Forus Health Pvt Ltd, Imagine Eyes, Nikon Corporation, and Topcon Corporation are among the leading companies in the Asia Pacific retinal imaging devices market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
The market for retinal imaging devices market is segmented into device type, and end user. Based on device type, the Asia Pacific retinal imaging devices market is segmented into fluorescein angiography, fundus camera, and optical coherence tomography. Based on end user, the retinal imaging devices market is segmented into hospitals & clinics, ambulatory surgical centers, specialized eye care centers, other end users. Geographically, the retinal imaging devices market is segmented into Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia Pacific).
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com